Potential for succes, but much is in limbo - Senior Principal Scientist bei Merck: Mitarbeiterbewertung

3.0
7. Jan. 2009
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Management is verbally supportive, but tends to operate in the dark.

Kontras

In process of reorganizing after merger with Organon - many areas have job cuts and there is a need to reestablish a structure to R&D.

Mehr Bewertungen zu Merck entdecken

5.0
3. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

End of the year shutdown which includes paid time off

Kontras

The con for me at the time was that I had to relocate which wasn’t possible

4.0
2. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Kontras

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle